Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus

The standard antiviral therapy for dialysis patients infected with hepatitis C virus (HCV) is (pegylated) interferon monotherapy, but its efficacy is insufficient. Oral direct-acting antiviral agents (DAAs) have recently been developed for chronic hepatitis C patients. However, some DAAs have contra...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Clin Cases
Главные авторы: Sato, Ken, Yamazaki, Yuichi, Ohyama, Tatsuya, Kobayashi, Takeshi, Horiguchi, Norio, Kakizaki, Satoru, Kusano, Motoyasu, Yamada, Masanobu
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2016
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792170/
https://ncbi.nlm.nih.gov/pubmed/26989674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v4.i3.88
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы